PULMONARY PHARMACOLOGY & THERAPEUTICS

Journal website Submission website

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

PULM PHARMACOL THER

ISSN / eISSN

1094-5539 / 1522-9629

Aims and Scope

Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews.

Research Areas Include:

• All major diseases of the lung
• Physiology
• Pathology
• Drug delivery
• Metabolism
• Pulmonary Toxicology.

Subject Area

PHARMACOLOGY & PHARMACY

RESPIRATORY SYSTEM

CiteScore

7.10

View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Pharmacology (medical)	Q1	#44/260
Medicine - Pulmonary and Respiratory Medicine	Q1	#28/144
Medicine - Biochemistry (medical)	Q2	#18/65

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
PHARMACOLOGY & PHARMACY - SCIE	Q3
RESPIRATORY SYSTEM - SCIE	Q3

H-index

Country/Area of Publication

ENGLAND

Publisher

Academic Press Inc.

Publication Frequency

Bimonthly

Year Publication Started

1997

Annual Article Volume

Open Access

Contact

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 24-28 OVAL RD, LONDON, ENGLAND, NW1 7DX

Popular journals in the same field
Recent articles

IRE1α/XBP-1 promotes β-catenin signaling activation of airway epithelium in lipopolysaccharide-induced acute lung injury: (2023) Hailing Zhang, Jiehong Li, Xilong Wang, Kai Wang, JianPeng Xie, Guanjin Chen, Yijian Li, Kai Zhong, Jiahui Li, Xin Chen

Real world outcomes of CFTR modulator therapy in Australian adults and children: (2023) Stephanie Kuek, Angela McCullagh, Eldho Paul, David Armstrong

The effect of bradykinin 1 receptor antagonist BI 1026706 on pulmonary inflammation after segmental lipopolysaccharide challenge in healthy smokers: (2023) Christina Gress, Jens Vogel-Claussen, Philipp Badorrek, Meike Müller, Kathrin Hohl, Marilisa Konietzke, Tobias Litzenburger, Wolfgang Seibold, Abhya G...

Effects of elexacaftor-tezacaftor-ivacaftor on daily treatment burden and airflow obstruction in adults with cystic fibrosis: (2023) Angelica Tiotiu, Iulia Ioan, Yves Billon

SIRT3 alleviates sepsis-induced acute lung injury by inhibiting pyroptosis via regulating the deacetylation of FoxO3a: (2023) Zheqian Wu, Yong Wang, Shijie Lu, Lili Yin, Lihua Dai

Impact of statin treatment and exposure on the risk of chronic allograft dysfunction in Chinese lung transplant recipients: (2023) Dan Zhang, Xiaoxing Wang, Wenwen Du, Wei Qin, Wenqian Chen, Xianbo Zuo, Pengmei Li

Safety and efficacy of transitioning from selexipag to oral treprostinil in pulmonary arterial hypertension: Findings from the ADAPT registry: (2023) D. Lachant, R. Minkin, J. Swisher, M. Mogri, R. Zolty, S. Hwang, S. Seaman, M. Broderick, S. Sahay

Assessing the relationship between cardiovascular and small airway disease and acute events in COPD: The ARCADIA study protocol: (2023) Paola Rogliani, Dejan Radovanovic, Josuel Ora, Nadia Starc, Stefano Verri, Elena Pistocchini, Luigino Calzetta

Safety and usefulness of nebulized liposomal amphotericin B: Systematic scoping review: (2023) Hideharu Hagiya, Yoshito Nishimura, Fumio Otsuka

Amygdalin epimers exert discrepant anti-pulmonary fibrosis activity via inhibiting TGF-β1/Smad2/3 pathway: (2023) Haoyan Jiao, Shuyu Li, Qingfa Tang

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started